Trials / Unknown
UnknownNCT04722198
Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Professor Lu Neurological Clinic · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to examine L. plantarum PS128 can improve symptoms in early onset PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with early onset PD will receive PS128 treatment for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | PS128 | daily ingestion 2 capsules of Lactobacillus plantarum PS128 (\>10 billion CFU/capsule) |
Timeline
- Start date
- 2020-10-27
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2021-01-25
- Last updated
- 2021-01-25
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04722198. Inclusion in this directory is not an endorsement.